How can you make a difference in the fight against Johne's disease?
New science and AI powered diagnostics can help you lead the way!
Johne’s is a chronic wasting disease of ruminants caused by Mycobacterium avium spp paratuberculosis (MAP), which greatly impacts on sustainability of the farming industry. Current tests fail at detecting early-stage Johne’s disease, allowing MAP to spread silently within herds.
MicroRNAs are powerful disease biomarkers that regulate biological processes. The new NEMO* technology analyses a microRNA panel with bespoke artificial intelligence (AI) to accurately identifies all MAP infections stages (I-IV) and predict likelihood of disease progression.
NEMO* allows farmers and clinicians to detect silent infections, understand resilience to disease, and act appropriately to protect the herd.
*NExtgen Mirna testing with Optimisation
LEARNING OBJECTIVES:
- Understand microRNAs and their use as disease biomarkers
- Learn about the power of AI and statistical modelling to diagnose Stage I Johne’s disease and predict disease progression
- Learn about the new NEMO* - Johne’s disease screening test and how it compares with current Johne’s testing methods
- Understand how early diagnosis of Johne’s disease (Stage I, pre-clinical, pre-shedding) is key for improving farming’s productive efficiency and achieve net zero by 2040
- Discover that the NEMO technology can potentially be applied to other veterinary diseases
Watch the recording below by clicking the play button:
About the Speaker
Dr Eve Hanks BVM&S CertAVP(EM) PhD MRCVS
CEO & Founder, MI:RNA Diagnostics
Dr Eve Hanks is CEO & Founder of MI:RNA Diagnostics. She is a veterinary surgeon with a certificate in medicine and a PhD in immunology and leads a team of ambitious entrepreneurial innovators, creating a new wave of veterinary diagnostics using cutting-edge science, ready to revolutionise the diagnostic market to protect animal welfare, give us more time with our pets, reduce GHG emissions from agriculture.
MI:RNA DIAGNOSTICS
MI:RNA is a veterinary diagnostics company focused on early disease diagnosis through the use of a revolutionary biomarker technology and artificial intelligence platform. The company was founded in 2019 by Dr Eve Hanks and is a spin out from SRUC.
The team have a vision to reduce disease through cutting edge science and are driven by their goals to help pets live longer, happier lives and to improve the welfare of farmed animals whilst protecting the environment from the impact of agriculture.
